Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Debt to Equity (2016 - 2025)

Angiodynamics' Debt to Equity history spans 15 years, with the latest figure at $0.03 for Q1 2025.

  • For Q1 2025, Debt to Equity fell 38.07% year-over-year to $0.03; the TTM value through Feb 2025 reached $0.03, down 38.07%, while the annual FY2024 figure was $0.02, 86.53% down from the prior year.
  • Debt to Equity reached $0.03 in Q1 2025 per ANGO's latest filing, up from $0.03 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.17 in Q2 2023 to a low of $0.01 in Q3 2023.
  • Average Debt to Equity over 5 years is $0.07, with a median of $0.06 recorded in 2021.
  • Peak YoY movement for Debt to Equity: surged 180.71% in 2021, then crashed 92.2% in 2023.
  • A 5-year view of Debt to Equity shows it stood at $0.06 in 2021, then skyrocketed by 152.48% to $0.15 in 2022, then plummeted by 83.97% to $0.02 in 2023, then increased by 13.51% to $0.03 in 2024, then grew by 1.29% to $0.03 in 2025.
  • Per Business Quant, the three most recent readings for ANGO's Debt to Equity are $0.03 (Q1 2025), $0.03 (Q4 2024), and $0.02 (Q3 2024).